Epocrates introduces products for
clinicians in Canada
SAN MATEO, Calif. – Epocrates Inc. announced its expansion into the
global market with the introduction of local brand and generic drug
names integrated into its clinical applications. The
solutions, including the Epocrates Rx free drug reference and the
Epocrates Essentials premium drug, disease and diagnostic guide, now
include drug name indexes for four countries – Canada, Germany, Spain
and the United Kingdom.
“Epocrates products have become invaluable to me, with immediate access
to current clinical information, such as drug dosing and interactions,
on my personal digital assistant. The addition of the local drug content
will help me provide even better care for my patients,” said Michael
Golbey, family physician, Kelowna, BC.
An Epocrates survey, conducted prior to the launch, found that nearly 90
percent of clinicians currently using Epocrates applications in the four
countries believe that using Epocrates has helped them avoid medical
errors, and more than 50 percent reported avoiding at least one medical
error a week.
Furthermore, nearly 30 reported saving more than 30 minutes per day by
using Epocrates, which often translates to more time with their
patients. Epocrates anticipates that use of the new customized drug
indexes will result in even greater patient safety and efficiency.
“With over 60,000 healthcare professionals outside of the U.S. actively
using our products today, we are well on our way to becoming a global
company,” said Kirk Loevner, chairman and chief executive office of
Epocrates. “We are committed to localizing our products to support
clinicians around the world in their pursuit to provide superior patient
care. We also look forward to working with international healthcare
companies seeking to communicate with our growing network of
The addition of the local drug indexes is Epocrates’ first step towards
making its products and services even more valuable to clinicians
outside of the United States. Epocrates will continue to enhance its
clinical content and add services, including news alerts, medical
education and market research. The Company also plans to expand into
additional countries, including France and Italy in 2006.
About Epocrates, Inc.
San Mateo, CA-based Epocrates is transforming the practice of medicine
by providing innovative clinical solutions at the point of care and
deploying leading-edge technologies that enable communication. The
company has built a clinical network connecting more than 500,000
healthcare professionals, including one in four U.S. physicians and
nearly one in two U.S. medical students, with the healthcare industry.
Epocrates’ products have shown a positive impact on patient safety,
healthcare efficiency and patient satisfaction. Epocrates was recently
ranked 257 in the 24th annual Inc.500 ranking of the fastest-growing
private companies in the country. For more information about Epocrates,
please visit www.epocrates.com.